Increasing dwell time of mitomycin C in the upper tract with a reverse thermosensitive polymer.
暂无分享,去创建一个
G. Preminger | J. Madden | B. Inman | Z. Goldsmith | A. Neisius | G. Astroza | M. Ferrandino | M. Lipkin | W. N. Simmons | Agnes J. Wang | M. W. Iqbal | Olugbemisola Oredein-Mccoy
[1] T. Kessler,et al. Antegrade perfusion with bacillus Calmette-Guérin in patients with non-muscle-invasive urothelial carcinoma of the upper urinary tract: who may benefit? , 2011, European urology.
[2] M. Elhilali,et al. The use of a novel reverse thermosensitive polymer to prevent ureteral stone retropulsion during intracorporeal lithotripsy: a randomized, controlled trial. , 2010, Journal of Urology.
[3] S. Landas,et al. Instillation of mitomycin C after transurethral resection of bladder cancer impairs wound healing: an animal model. , 2008, Anticancer research.
[4] W. Mcdougal,et al. Preventing migration of stones during fragmentation with thermosensitive polymer. , 2007, Journal of endourology.
[5] G. Preminger,et al. Ureteral access sheath provides protection against elevated renal pressures during routine flexible ureteroscopic stone manipulation. , 2004, Journal of endourology.
[6] J. Huguet,et al. Percutaneous nephroscopic management of upper urinary tract transitional cell carcinoma: recurrence and long-term followup. , 2004, The Journal of urology.
[7] R. Sylvester,et al. A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials. , 2004, The Journal of urology.
[8] G. Chen,et al. Ureteroscopic management of upper tract transitional cell carcinoma in patients with normal contralateral kidneys. , 2000, The Journal of urology.
[9] M. Blute,et al. Is nephroureterectomy necessary in all cases of upper tract transitional cell carcinoma? Long-term results of conservative endourologic management of upper tract transitional cell carcinoma in individuals with a normal contralateral kidney. , 1999, Urology.
[10] Peter Clark,et al. 13-year experience with percutaneous management of upper tract transitional cell carcinoma. , 1999 .
[11] F. Keeley,et al. Adjuvant mitomycin C following endoscopic treatment of upper tract transitional cell carcinoma. , 1997, The Journal of urology.
[12] N. Bodsworth,et al. Valaciclovir for the suppression of recurrent genital HSV infection: a placebo controlled study of once daily therapy. International Valaciclovir HSV Study Group. , 1997, Genitourinary medicine.
[13] M. Parmar,et al. The effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: a further report with 7 years of follow up. , 1996, The Journal of urology.
[14] T. A. Hatton,et al. Poly(ethylene oxide)-poly(propylene oxide )-poly (ethylene oxide) block copolymer surfactants in aqueous solutions and at interfaces: thermodynamics, structure, dynamics, and modeling , 1995 .
[15] J. Eastham,et al. Technique of mitomycin C instillation in the treatment of upper urinary tract urothelial tumors. , 1993, The Journal of urology.
[16] W. Whitmore,et al. Endoscopic diagnosis and treatment of upper‐tract urothelial tumors. A preliminary report , 1985, Cancer.
[17] G. Fuchs,et al. New techniques for the administration of topical adjuvant therapy after endoscopic ablation of upper urinary tract transitional cell carcinoma. , 1998, The Journal of urology.
[18] R. Kohler. Investigations on backflow in retrograde pyelography; a roentgenological and clinical study. , 1953, Acta radiologica.
[19] E. Berven. Hugo Ahlbom: in memoriam. , 1953 .